Most dementia is not directly inherited. The vast majority of cases result from a complex mix of genetic susceptibility, lifestyle, and environmental factors rather than a single gene passed from parent to child. Only a small fraction of dementia, roughly 5% or less depending on the type, follows a clear hereditary pattern where a mutation in one gene virtually guarantees the disease will develop. Understanding the difference between these two categories can help you make sense of your own family history.
Hereditary vs. Genetic Risk
There’s an important distinction between a disease being “hereditary” and being “genetic.” Hereditary means a specific gene mutation is passed directly from parent to child, and inheriting that mutation makes the disease highly likely or certain. Genetic risk, on the other hand, means certain gene variants increase your chances of developing a condition without making it inevitable. Most dementia falls into the second category.
Think of it this way: inheriting a deterministic mutation is like inheriting a loaded blueprint. Inheriting a risk gene is more like inheriting a tendency, one that may or may not lead to disease depending on dozens of other factors including your cardiovascular health, education, physical activity, and even how well you sleep over a lifetime.
Alzheimer’s Disease: Two Genetic Paths
Alzheimer’s accounts for the majority of dementia cases, and it has two genetically distinct forms. The rare hereditary form, called autosomal dominant Alzheimer’s, is caused by mutations in one of three genes. A person who inherits any one of these mutations from either parent is likely to develop Alzheimer’s symptoms before age 65, often between ages 30 and 60. This form accounts for less than 1% of all Alzheimer’s cases.
The far more common form, late-onset Alzheimer’s, doesn’t follow a simple inheritance pattern. The strongest known genetic risk factor is a variant of the APOE gene called APOE4. Everyone carries two copies of the APOE gene, and the version you inherit matters. People who carry two copies of the APOE4 variant have roughly a 60% chance of developing Alzheimer’s dementia by age 85. That’s a dramatically elevated risk, but it’s still not a guarantee. Plenty of people with two copies never develop the disease, and many people with Alzheimer’s carry no APOE4 at all.
Having one copy of APOE4 raises your risk to a lesser degree. Having zero copies doesn’t eliminate your risk entirely. This is what makes Alzheimer’s genetics so frustrating for families: a parent’s diagnosis raises your statistical likelihood, but it doesn’t determine your fate.
Frontotemporal Dementia Has the Strongest Hereditary Link
Among the major types of dementia, frontotemporal dementia (FTD) has the highest rate of direct inheritance. About 10 to 20% of all FTD cases are considered genetic, caused by a single identifiable mutation. Up to 40% of people with FTD report a family history of the disease, though not all of those families carry a known mutation. Some cases classified as “familial” likely involve risk genes that haven’t been fully characterized yet.
Because of this strong genetic component, genetic testing is recommended for all individuals diagnosed with FTD, not just those with a clear family history. A monogenic cause is identified in about 10% of familial cases and 5 to 6% of cases that appear sporadic, which means even people with no known family history sometimes carry a causative mutation.
Lewy Body Dementia and Shared Genetic Threads
Lewy body dementia (LBD) sits at a genetic crossroads with both Alzheimer’s and Parkinson’s disease. Research from the NIH identified five genes whose sequences differed significantly between people with LBD and healthy controls. Three of these genes, SNCA, APOE, and GBA, had been linked to the disease before. Two others were newly implicated and may also play roles in Alzheimer’s and Parkinson’s.
The GBA gene appears to have a particularly strong influence. It provides instructions for a protein that helps cells break down certain fats. Both common and rare variants in this gene are tied to Lewy body dementia. Mutations in the same gene also cause Gaucher disease, a metabolic condition, which is why genetic testing for LBD is recommended if there’s a family history of Parkinson’s, other dementias, or Gaucher disease. In rare cases, mutations in the SNCA gene, which codes for the main protein found in Lewy bodies, can directly cause the disease.
Vascular Dementia Is Mostly Not Inherited
Vascular dementia results from reduced blood flow to the brain, usually due to strokes or chronic damage to small blood vessels. Its primary risk factors are the same ones that drive heart disease: high blood pressure, diabetes, smoking, and high cholesterol. Genetics play a background role through their influence on these cardiovascular risk factors, but vascular dementia itself is rarely inherited directly.
The notable exception is CADASIL, a rare inherited disorder caused by a mutation in the Notch3 gene. This mutation causes the walls of small blood vessels in the brain to thicken progressively, blocking blood flow. CADASIL typically causes migraines, recurrent strokes, and cognitive decline starting in mid-adulthood. It follows a straightforward inheritance pattern: a child of an affected parent has a 50% chance of inheriting the mutation.
What a Family History Actually Means for You
Having a parent or sibling with dementia does increase your risk, but the size of that increase depends heavily on the type of dementia, the age it appeared, and how many relatives are affected. The strongest signals pointing toward a hereditary cause are three or more affected family members across two generations connected by a first-degree relative, or any case of dementia diagnosed before age 60.
A single parent developing Alzheimer’s in their late 70s or 80s raises your risk modestly compared to the general population, but this is the most common scenario and the one least likely to involve a deterministic gene. Late-onset dementia in one family member is more a reflection of age being the single biggest risk factor for the disease than evidence of a strong genetic cause.
If your family history is more concerning, perhaps a parent and grandparent both diagnosed young, or multiple siblings affected, genetic counseling can help you understand what testing might reveal and what it wouldn’t. Testing the affected family member first is standard practice, because it’s far easier to interpret a negative result in an unaffected person if the family’s specific mutation is already known.
What Genetic Testing Can and Can’t Tell You
Genetic testing for dementia is most useful when there’s a clear clinical reason to pursue it. For someone with early-onset symptoms and a strong family history, a multigene panel can identify mutations that confirm a diagnosis and clarify the risk for other family members. For frontotemporal dementia, testing is broadly recommended regardless of family history because hidden mutations are common enough to justify it.
For the average person worried about late-onset Alzheimer’s, genetic testing is less straightforward. You can learn your APOE status through some commercial tests, but knowing you carry one or even two copies of APOE4 doesn’t tell you whether you’ll develop the disease. It tells you your risk is elevated, which may be motivating for some people and anxiety-inducing for others, without changing the basic recommendations: stay physically active, manage blood pressure, maintain social connections, protect your sleep, and address hearing loss early.
If a standard gene panel comes back negative but a hereditary cause is still strongly suspected, more comprehensive testing like whole-exome or whole-genome sequencing can sometimes uncover rarer variants. The field is still identifying new risk genes. Researchers recently discovered genetic variants on chromosome 5 associated with late-onset Alzheimer’s in people with African ancestry, and a separate study found a gene on the X chromosome specifically associated with Lewy body dementia in women. The genetic map of dementia is still being drawn, which means a negative test today doesn’t rule out a genetic contribution that science hasn’t yet characterized.